Header Logo

Connection

ADAM VOGEL to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications ADAM VOGEL has written about Antineoplastic Agents.
ADAM VOGEL
Connection Strength
0.091
Antineoplastic Agents
  1. Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial. ESMO Open. 2021 Dec; 6(6):100310.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.